Dopa-responsive Dystonia with a Novel Initiation Codon Mutation in the GCH1 Gene Misdiagnosed as Cerebral Palsy by Lee, Jae-Hyeok et al.
© 2011 The Korean Academy of Medical Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
pISSN 1011-8934
eISSN 1598-6357
Dopa-responsive Dystonia with a Novel Initiation Codon 
Mutation in the GCH1 Gene Misdiagnosed as Cerebral Palsy
Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by childhood-onset 
dystonia and a dramatic response to relatively low doses of levodopa. However, patients 
with DRD can be misdiagnosed as cerebral palsy or spastic diplegia due to phenotypic 
variation. Here we report a young woman with DRD who were severely disabled and 
misdiagnosed as cerebral palsy for over 10 yr. A small dose of levodopa restored 
wheelchair-bound state to normality. However, thoracolumbar scoliosis has remained as a 
sequel due to late detection of DRD. Genetic analysis by using PCR-direct sequencing 
revealed a novel initiation codon mutation (c.1A>T; p.Met1Leu) in GTP cyclohydrolase 1 
(GCH1) gene. Although it is known that DRD can be misdiagnosed as cerebral palsy, this 
case reinforces the importance of differential diagnosis of DRD from cerebral palsy.
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INTRODUCTION 
Dopa-responsive dystonia (DRD) is a progressive primary dys-
tonia that is characterized by onset during childhood, circadian 
fluctuation of symptoms and a dramatic and sustained response 
to low doses of oral administration of levodopa (1). DRD is fre-
quently caused by GTP-cyclohydrolase 1 (GTPCH1) deficiency 
that up to 87% of the DRD is caused by mutations in the GCH1 
gene encoding GTPCH1 (2, 3). 
  Although it is well-known that the clinical features of GTPCH1-
deficiency can be extremely variable including benign adult-on-
set parkinsonism, various types of focal dystonia, DRD simulat-
ing cerebral palsy or spastic paraplegia, clinical diagnosis is still 
a challenge in some instances (4).
  In Korea, there has been a few reports on the patients with 
DRD carrying the GCH1 mutations (5-10). Here, we report a 
young woman with a novel initiation codon mutation in the 
GCH1 gene who was severely disabled and misdiagnosed as ce-
rebral palsy over than 10 yr. 
CASE DESCRIPTION
She was referred to our clinic when she was 30 on February 22, 
2009. She developed well until the age of 8 yr when an abnormal 
tiptoe gait was observed. It resulted in frequent falls. Her symp-
toms were mild in the morning and more prominent toward the 
end of the day. As the disease progressed, she had pes equin-
ovarus posture at rest in both feet. At the age 15 she needed the 
support of two people to walk a short distance and started to use 
a wheelchair. At this age she also experienced stiffness and twist-
ing in upper limbs, neck, and trunk. She found it difficult to write 
and use a chopstick. Her birth and developmental history was 
unremarkable. She had no prior history of head injury, meningi-
tis, encephalitis, or febrile seizures. There was no known history 
of motor disorder in her family. She was initially diagnosed as 
having cerebral palsy. Brain CT was normal. She received phys-
iotherapy and muscle relaxants with no benefit. When she was 
20, Madopar
® 250 mg was prescribed by neurologist. Her symp-
toms dramatically improved within days, and she could walk 
independently.  She had been taking levodopa 200 mg/day for 
10 yr with sustained benefit without emergence of motor fluc-
tuations or other neurologic manifestations. She felt well and 
was leading a normal life. The fixed scoliotic deformity of thora-
columbar spine was noted on chest radiogrdaphy (Fig. 1). Ge-
netic testing using direct sequencing revealed a novel initiation 
codon mutation (c.1A>T; p.Met1Leu) in the GCH1 gene (Fig. 2). Lee J-H, et al.  •  GCH1-related Dopa-responsive Dystonia Misdiagnosed as Cerebral Palsy 
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DISCUSSION
DRD-causing mutations in GCH1 include point mutations, small 
insertions, deletions and whole exon deletions (2, 11). We iden-
tified a novel mutation in the initiation codon. We speculate that 
the GCH1 dysfunction caused by c.1A>T is similar to that caused 
by the previously reported mutations, c.2T>C (p.M1T) and c.3G> 
C (p.M1I) (12, 13). The initiation codon mutation abolishes the 
first start codon AUG, which might interfere the translation of 
GCH1 gene and cause a decrease in GTPCH1 (enzyme) activity. 
All three cases with initiation codon mutation presented typical 
clinical features of DRD, characterized by childhood-onset, start-
ed in the legs, and had foot dystonia with equinovarus posture. 
However, it is difficult to establish a genotype-phenotype corre-
lation because of the limited data.
  The classic phenotypic form of DRD presents with childhood-
onset foot dystonia, which gradually progresses to other parts 
of the body, and shows marked diurnal fluctuations with wors-
ening of the symptoms toward the evening and improvement 
after sleep (1). Many patients have features of parkinsonism, in-
cluding rigidity, bradykinesia, flexed posture, and loss of postur-
al reflexes. Intellectual, cerebellar, sensory, or autonomic distur-
bances usually do not occur. However, atypical clinical features 
may include focal dystonia, spasticity, no dystonia prior to the 
onset of parkinsonism in mid- or late adulthood, and absence 
of diurnal fluctuation, making diagnosis difficult (11). Our pa-
tient was initially misdiagnosed as having cerebral palsy. In pre-
vious series, up to 24% of patients with DRD had been misdiag-
nosed as cerebral palsy (14). Hyperreflexia, ankle clonus, and 
other clinical features suggesting spasticity may cause confusion 
with cerebral palsy. Due to lack of medical records, we were not 
aware of detailed neurologic findings at pre-treatment state. How-
ever, the clinical clues to suggest DRD, such as no developmen-
tal abnormalities in early childhood, progressive course, and di-
urnal fluctuation of symptoms, had been overlooked by her cli-
nicians. 
  The hallmark of DRD in most cases is a dramatic and persis-
tent response to levodopa (14). Long-term treatment with low 
dose levodopa is not associated with the motor fluctuations that 
are seen with levodopa therapy in juvenile (and adult) Parkin-
son’s disease. A small dose restored a wheelchair bound disabled 
our patient to normality. However, thoracolumbar scoliosis has 
remained as a sequela due to late detection of DRD. The prog-
nosis of secondary orthopedic deformities has directly related 
to the timing of diagnosis and the initiation of levodopa therapy 
(15). Some patients have shown remarkable responsiveness to 
levodopa with spontaneous resolution of the abnormal spinal 
curvatures. Therefore, a diagnostic levodopa trial is warranted 
as soon as possible in patients with early onset dystonia or atyp-
ical cerebral palsy of unknown etiology.
Fig. 1. Chest X-ray show fixed scoliotic deformity. The major scoliosis is concentrated 
in the thoracic region and curves to the right.
Fig. 2. Sequence analysis of the GCH1 gene identi-
fied a heterozygous mutation of the first nucleotide 
(arrow) in the ATG translation initiation site (c.1A>T; 
p.Met1Leu).
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